Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Non-invasive heart monitor tested against standard method in shock patients

NCT ID NCT02728791

Knowledge-focused Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compared a non-invasive device (ClearSight) with a standard invasive method (transpulmonary thermodilution) for measuring heart function in 42 ICU patients with shock or low cardiac output. The goal was to see if the non-invasive device could be used routinely. Researchers looked at how well the two methods agreed on cardiac index, blood pressure, and stroke volume.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the non-invasive device proves accurate enough, it could replace invasive monitoring in some ICU patients, reducing complications.
What could go wrong
This is a small, completed correlation study (42 patients) that only compares measurements; it does not test whether using the device improves patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

42 people

The number who actually took part.

Started

May 2016

Finished

Jul 2018

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults patients hospitalized in ICU with hemodynamic failure requiring vasoactive drugs

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * age\>18 * hospitalized in surgical ICU, with hemodynamic instability or vaso-active drugs * No opposition formulated Exclusion Criteria: * Impossibility of establishment of one of the cardiac output measurement devices * Pregnant woman * Refuse to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiac output, low are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cardiac Output, Low Shock

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiac output, low Shock

Contacts and locations

Locations

  • CHRU BREST, Hôpital de la Cavale Blanche

    Brest, 29200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.